Gratis Versand ab € 16,99. Mehr Infos.
Bookbot

NASH, An Issue of Clinics in Liver Disease

Parameter

  • 240 Seiten
  • 9 Lesestunden

Mehr zum Buch

Although effective treatments for Non-alcoholic Steatohepatitis (NASH) are yet to be developed, several potentially promising treatment approaches are under investigation. This issue of Clinics in Liver Diseases presents the views of several internationally renowned NAFLD experts on the most up to date epidemiology, natural history, diagnosis, pathogenesis, and treatment of NAFLD. Additionally, this issue presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery. Experts discuss the role of new technologies, such as genomics and proteomics, in understanding NAFLD and developing new biomarkers, including fibrosis markers. Presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery.

Buchkauf

NASH, An Issue of Clinics in Liver Disease, Zobair M. Younossi

Sprache
Erscheinungsdatum
2007
product-detail.submit-box.info.binding
(Hardcover)
Wir benachrichtigen dich per E-Mail.

Lieferung

  • Gratis Versand ab 16,99 € in ganz Österreich! Mehr Infos.

Zahlungsmethoden

Keiner hat bisher bewertet.Abgeben

Titel
NASH, An Issue of Clinics in Liver Disease
Sprache
Englisch
Verlag
Saunders
Erscheinungsdatum
2007
Einband
Hardcover
Seitenzahl
240
ISBN10
141604289X
ISBN13
9781416042891
Reihe
Beschreibung
Although effective treatments for Non-alcoholic Steatohepatitis (NASH) are yet to be developed, several potentially promising treatment approaches are under investigation. This issue of Clinics in Liver Diseases presents the views of several internationally renowned NAFLD experts on the most up to date epidemiology, natural history, diagnosis, pathogenesis, and treatment of NAFLD. Additionally, this issue presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery. Experts discuss the role of new technologies, such as genomics and proteomics, in understanding NAFLD and developing new biomarkers, including fibrosis markers. Presents recent work on to the importance of NAFLD in children, as well as in the individuals who undergo weight reduction surgery.